The optimal standard dose of the intravenous sedation by using midazolam and propofol for dental procedure

The optimal standard dose of the intravenous sedation by using midazolam and propofol for dental procedure - The optimal standard dose of the intravenous sedation by using midazolam and propofol for dental procedure

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014228

Enrollment

1000

Registered

2014-06-11

Start date

2012-01-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental procedure under intravenous sedation

Interventions

This study was a prospective study performed for a period of 16 months beginning in January 2012. First, 1 mg of midazolam was given, and the additional bolus of every 1 mg every min was allowed until

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Physical status of the enrolled patients are American Society of Anesthesiologists (ASA) class 1-2, aged 20 years old and above, who undergo intravenous sedation for dental procedure.

Exclusion criteria

Exclusion criteria: Those patients who have allergies to midazolam or propofol, dementia, intellectual disability or cerebral palsy, are excluded.

Design outcomes

Primary

Measure	Time frame
Patient and dentist satisfaction for intravenous sedation	—

Countries

Japan

Contacts

Public ContactRikuo Masuda

Showa University School of Dentistry Department of Perioperative Medicine, Division of Anesthesiology

rikuo14@dent.showa-u.ac.jp03-3787-1151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026